Page last updated: 2024-08-24

bisnafide and Neoplasms

bisnafide has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Behrens, CH; Cheshire, PJ; Dexter, DL; Gross, JL; Hallman, JC; Houghton, JA; Houghton, PJ; McRipley, RJ; Sun, JH1
Brogdon, BL; Garner, DM; Gray, JE; Lai, CM; Peterman, VC; Pieniaszek, HJ1
Avery, L; Bowman, L; Pappo, A; Pratt, CB; Stewart, CF; Thompson, J; Zamboni, WC1

Trials

1 trial(s) available for bisnafide and Neoplasms

ArticleYear
Phase I study of DMP 840 in pediatric patients with refractory solid tumors.
    Investigational new drugs, 1998, Volume: 16, Issue:1

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Humans; Isoquinolines; Mesylates; Neoplasms; Thrombocytopenia; Treatment Outcome

1998

Other Studies

2 other study(ies) available for bisnafide and Neoplasms

ArticleYear
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers.
    Cancer chemotherapy and pharmacology, 1994, Volume: 33, Issue:4

    Topics: Adenocarcinoma; Adolescent; Adult; Analysis of Variance; Animals; Antineoplastic Agents; Child; Colonic Neoplasms; Drug Resistance; Female; Humans; Isoquinolines; Mesylates; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Neoplasms; Rhabdomyosarcoma; Topoisomerase I Inhibitors; Treatment Outcome; Tumor Cells, Cultured

1994
Determination of bisnafide, a novel bis-naphthalimide anticancer agent, in human plasma by high-performance liquid chromatography with UV detection.
    Journal of pharmaceutical and biomedical analysis, 1998, Volume: 17, Issue:3

    Topics: Antineoplastic Agents; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Humans; Isoquinolines; Mesylates; Neoplasms; Spectrophotometry, Ultraviolet; Time Factors

1998